Treatment of Facial (Chin) Staph Infection
For a staph infection on the chin, antibiotic therapy is mandatory because facial abscesses are in an area difficult to drain and carry higher risk—combine incision and drainage (if an abscess is present) with empirical oral antibiotics covering community-acquired MRSA. 1
Key Treatment Algorithm
Step 1: Determine if Drainage is Needed
- If abscess present: Incision and drainage is essential 1
- If cellulitis only (no drainable collection): Proceed directly to antibiotics
Step 2: Antibiotic Selection (Empirical Coverage for CA-MRSA)
The chin qualifies as a "difficult to drain" facial location, making antibiotics mandatory regardless of whether drainage is performed 1. Choose one of these oral regimens:
First-line options:
- Clindamycin 300-450 mg three times daily (covers both MRSA and streptococci) 1
- TMP-SMX 1-2 double-strength tablets twice daily PLUS amoxicillin 500 mg three times daily (TMP-SMX for MRSA, amoxicillin for streptococci) 1
- Doxycycline 100 mg twice daily PLUS amoxicillin (same rationale) 1
Alternative:
- Linezolid 600 mg twice daily (covers both MRSA and streptococci, but expensive) 1
Step 3: Duration and Monitoring
- 5-10 days of therapy, individualized based on clinical response 1, 2
- Obtain culture from any purulent drainage to guide therapy adjustment 1
- Re-evaluate in 24-48 hours to verify clinical response 3
Critical Considerations for Facial Infections
Why facial location changes management: The IDSA guidelines explicitly state that abscesses in areas difficult to drain (face, hand, genitalia) require antibiotic therapy even when drainage is performed 1. This is because:
- Incomplete drainage is more likely in facial locations
- Risk of complications (cavernous sinus thrombosis, intracranial extension)
- Cosmetic concerns limit aggressive surgical approaches
MRSA coverage is essential: Community-acquired MRSA now predominates in skin infections, making empirical coverage mandatory 1. Do not use beta-lactams alone (like cephalexin or dicloxacillin) as initial therapy unless you have culture data confirming methicillin-susceptible staph 3.
Common Pitfalls to Avoid
Don't skip antibiotics for facial abscesses: Unlike simple abscesses on the trunk or extremities where drainage alone may suffice, facial location mandates antibiotic therapy 1
Don't use TMP-SMX or doxycycline alone: These agents lack reliable streptococcal coverage. If using these for MRSA coverage, add a beta-lactam like amoxicillin 1
Don't use rifampin: Either as monotherapy or adjunctive therapy—it's not recommended for skin infections 1
Avoid tetracyclines in children <8 years and pregnant women 1
When to Hospitalize
Consider IV antibiotics and admission if:
- Signs of systemic illness (fever, tachycardia, hypotension)
- Rapid progression despite oral therapy
- Extensive cellulitis involving multiple facial areas
- Immunocompromised patient
- Failed outpatient management
IV options: Vancomycin, linezolid 600 mg IV twice daily, daptomycin 4 mg/kg daily, or clindamycin 600 mg IV three times daily 1
Adjusting Therapy Based on Culture Results
- If MSSA confirmed: Switch to cephalexin 500 mg four times daily or dicloxacillin 500 mg four times daily 3
- If MRSA confirmed: Continue current MRSA-active regimen
- If no growth and improving: Complete the antibiotic course as prescribed